← Back to Search

Behavioral Intervention

Neurological Influences on Drug Prevention Intervention

Phase 1 & 2
Waitlist Available
Led By William W. Latimer, PhD, MPH
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* 11 to 15 year old middle school students
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3,6,9,12, and 18 month assessment
Awards & highlights
No Placebo-Only Group

Summary

In this R01 study, a randomized clinical trial is proposed to evaluate the efficacy of a drug abuse prevention intervention for indicated middle school youth that coordinates family and teen-based components. The Family Management Intervention is comprised of a parent-focused curriculum to foster parenting skills followed by brief family therapy to foster adaptive family communication and age-appropriate roles. The Teen Achievement Intervention is comprised of a clinician-delivered learning strategy curriculum to foster academic achievement followed by a similar yet peer-facilitated curriculum to foster self-efficacy and prosocial peer networks. In the first study aim, we seek to evaluate the separate and possibly synergistic effects of the Family Management and Teen Achievement components on post intervention drug use, problem behavior, psychological distress, and academic achievement of indicated youth. Innovative analytic strategies are subsequently used to elucidate mediated pathways by which the interventions might reduce drug involvement and problem behavior by promoting changes in targeted skills and behavior change processes. The possibility of effect-modification also is considered, with a focus on neurocognitive, internalizing/externalizing, and demographic factors, in an effort to discern why interventions work for some youth but not others. This application revision has sought to address well-taken concerns cited by the reviewers while maintaining proposal strengths. In response to a key limitation, this revision includes further specification of anticipated relationships between neurocognitive variables, skill acquisition levels, and prevention intervention outcomes among indicated youth. Study hypotheses on specific neurocognitive effects are informed by empirical findings and the clinical experience of investigative team members specializing in neuropsychology. If successful, this project should improve prevention practices by identifying malleable behavior change processes fostered by effective interventions. Improving our understanding of how individual characteristics of indicated youth, such as neurocognitive deficits or externalizing problems, influence the development of skills during interventions and subsequent outcomes may also help to improve existing prevention interventions. The significance of the proposed study is underscored further by the substantial size of the targeted population of indicated youth, and the range of morbidities and mortality that often result when early warning signs of drug abuse are not addressed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3,6,9,12, and 18 month assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3,6,9,12, and 18 month assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alcohol use abstinence and frequency
Marijuana use abstinence and frequency
Other drug use abstinence and frequency
Secondary study objectives
Academic achievement
Family functioning
Learning Strategy Skill
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Intergrated Family and Cognitve Behavioral TherapyExperimental Treatment1 Intervention
Participants assigned to the IFCBT arm received the Cognitive Behavioral Therapy and Family Therapy intervention components.
Group II: Family TherapyExperimental Treatment1 Intervention
Participants assigned to the Family Therapy arm received a family-centered intervention to support targeted adolescent behavior change. The family therapy component of IFCBT includes engagement, active treatment, and maintenance phases.
Group III: Conitive Behavorial TherapyExperimental Treatment1 Intervention
The cognitive-behavioral program introduces youths to problem-solving behavior change principles and study skills to promote school achievement.
Group IV: PsychoeducationActive Control1 Intervention
Drug education curriculum was delivered to participants assigned to this condition.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Integrated Family and Cognitive-Behavioral Drug Prevention Intervention
2005
Completed Phase 2
~330

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,843 Previous Clinical Trials
8,172,903 Total Patients Enrolled
University of FloridaLead Sponsor
1,409 Previous Clinical Trials
766,893 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,339 Previous Clinical Trials
14,881,301 Total Patients Enrolled
William W. Latimer, PhD, MPHPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health
1 Previous Clinical Trials
836 Total Patients Enrolled
~16 spots leftby Jan 2026